Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis

被引:5
作者
Pandey, Ekta [1 ]
Harris, Edward N. [1 ]
机构
[1] Univ Nebraska, Beadle Ctr, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA
来源
MOLECULAR THERAPY-NUCLEIC ACIDS | 2023年 / 33卷
关键词
LOW-DENSITY-LIPOPROTEIN; CELLULAR UPTAKE; INTRACELLULAR TRAFFICKING; HYALURONAN RECEPTOR; DERMATAN SULFATE; DELIVERY; RELEASE; HEPARIN; BINDING; GENE;
D O I
10.1016/j.omtn.2023.07.019
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-DNA-binding Stabilin-2/HARE receptors expressed on liver sinusoidal endothelial cells specifically bind to and internalize several classes of phosphorothioate antisense oligonucleotides (PS-ASOs). After Stabilin-mediated uptake, PS-ASOs are trafficked within endosomes (>97%-99%), ultimately resulting in destruction in the lysosome. The ASO entrapment in endosomes lowers therapeutic efficacy, thereby increasing the overall dose for patients. Here, we use confocal microscopy to characterize the intracellular route transverse by PS-ASOs after Stabilin receptor-mediated uptake in stable recombinant Stabilin-1 and-2 cell lines. We found that PS-ASOs as well as the Stabilin-2 receptor transverse the classic path: clathrincoated vesicle-early endosome-late endosome-lysosome. Chloroquine exposure facilitated endosomal escape of PS-ASOs leading to target knockdown by more than 50% as compared to untreated cells, resulting in increased PS-ASO efficacy. We also characterize cytosolic galectins as novel contributor for PS-ASO escape. Galectins knockdown enhances ASO efficacy by more than 60% by modulating EEA1, Rab5C, and Rab7A mRNA expression, leading to a delay in the endosomal vesicle maturation process. Collectively, our results provide additional insight for increasing PS-ASO efficacy by enhancing endosomal escape, which can further be utilized for other nucleic acid-based modalities.
引用
收藏
页码:430 / 443
页数:14
相关论文
共 65 条
  • [11] The Limitless Future of RNA Therapeutics
    Damase, Tulsi Ram
    Sukhovershin, Roman
    Boada, Christian
    Taraballi, Francesca
    Pettigrew, Roderic I.
    Cooke, John P.
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [12] "Repair Me if You Can": Membrane Damage, Response, and Control from the Viral Perspective
    Daussy, Coralie F.
    Wodrich, Harald
    [J]. CELLS, 2020, 9 (09) : 1 - 30
  • [13] Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
    Dhuri, Karishma
    Bechtold, Clara
    Quijano, Elias
    Ha Pham
    Gupta, Anisha
    Vikram, Ajit
    Bahal, Raman
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [14] Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
    Di Fusco, Davide
    Dinallo, Vincenzo
    Marafini, Irene
    Figliuzzi, Michele M.
    Romano, Barbara
    Monteleone, Giovanni
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [15] Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
    Dings, Ruud P. M.
    Miller, Michelle C.
    Nesmelova, Irina
    Astorgues-Xerri, Lucile
    Kumar, Nigam
    Serova, Maria
    Chen, Xuimei
    Raymond, Eric
    Hoye, Thomas R.
    Mayo, Kevin H.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5121 - 5129
  • [16] Mechanisms of Endocytosis
    Doherty, Gary J.
    McMahon, Harvey T.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 : 857 - 902
  • [17] Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Dowdy, Steven F.
    Setten, Ryan L.
    Cui, Xian-Shu
    Jadhav, Satish G.
    [J]. NUCLEIC ACID THERAPEUTICS, 2022, 32 (05) : 361 - 368
  • [18] Imaging small molecule-induced endosomal escape of siRNA
    Du Rietz, Hampus
    Hedlund, Hampus
    Wilhelmson, Sten
    Nordenfelt, Pontus
    Wittrup, Anders
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [19] Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
    Geary, Richard S.
    Norris, Daniel
    Yu, Rosie
    Bennett, C. Frank
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 46 - 51
  • [20] New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer
    Gheysen, Laetitia
    Soumoy, Laura
    Trelcat, Anne
    Verset, Laurine
    Journe, Fabrice
    Saussez, Sven
    [J]. CELLS, 2021, 10 (05)